Population‐based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976–1995
RA Mesa, MN Silverstein, SJ Jacobsen… - American journal of …, 1999 - Wiley Online Library
To provide basic information about occurrence and outcome of essential thrombocythemia
(ET) and agnogenic myeloid metaplasia (AMM), we used the Rochester Epidemiology …
(ET) and agnogenic myeloid metaplasia (AMM), we used the Rochester Epidemiology …
Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients
F Cervantes, A Alvarez‐Larrán, C Talarn… - British journal of …, 2002 - Wiley Online Library
Myelofibrotic transformation is a known complication of essential thrombocythaemia (ET),
but information on its incidence, presenting features and evolution is scarce. In a series of …
but information on its incidence, presenting features and evolution is scarce. In a series of …
Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors
AP Wolanskyj, SM Schwager, RF McClure… - Mayo Clinic …, 2006 - Elsevier
OBJECTIVE To describe the long-term natural history of essential thrombocythemia (ET) in
terms of life expectancy, risk of disease transformation into a more aggressive myeloid …
terms of life expectancy, risk of disease transformation into a more aggressive myeloid …
Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients
N Gangat, AP Wolanskyj, RF McClure, CY Li… - Leukemia, 2007 - nature.com
Unlike the case with thrombosis, prognostic models for survival and leukemic transformation
(LT) in essential thrombocythemia (ET) are not available. Among 605 patients with ET seen …
(LT) in essential thrombocythemia (ET) are not available. Among 605 patients with ET seen …
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study
Purpose The WHO diagnostic criteria underscore the role of bone marrow (BM) morphology
in distinguishing essential thrombocythemia (ET) from early/prefibrotic primary myelofibrosis …
in distinguishing essential thrombocythemia (ET) from early/prefibrotic primary myelofibrosis …
Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia
M Bazzan, G Tamponi, P Schinco, A Vaccarino… - Annals of …, 1999 - Springer
A total of 187 consecutive patients with essential thrombocythemia (ET) were diagnosed and
followed by our Hematology Department in the period October 1980–November 1994. The …
followed by our Hematology Department in the period October 1980–November 1994. The …
Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia
CS Chim, YL Kwong, AKW Lie, SK Ma… - Archives of internal …, 2005 - jamanetwork.com
Background Essential thrombocythemia (ET) is a clonal myeloproliferative disease
associated with thrombohemorrhagic complications and myeloid transformation to diseases …
associated with thrombohemorrhagic complications and myeloid transformation to diseases …
Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia)
JJ Michiels, J Thiele - International journal of hematology, 2002 - Springer
A set of clinical and pathological criteria for the diagnosis and staging of Philadelphia
chromosome-negative myeloproliferative disorders (Ph 1--MPDs) is presented by including …
chromosome-negative myeloproliferative disorders (Ph 1--MPDs) is presented by including …
One thousand patients with essential thrombocythemia: the Mayo Clinic experience
N Gangat, O Karrar, A Al-Kali, KH Begna… - Blood cancer …, 2024 - nature.com
We describe 1000 patients with essential thrombocythemia seen at the Mayo Clinic between
1967 and 2023: median age 58 years (18–90), females 63%, JAK2/CALR/MPL-mutated …
1967 and 2023: median age 58 years (18–90), females 63%, JAK2/CALR/MPL-mutated …
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
Background Essential thrombocythemia is a chronic myeloproliferative disorder; patients
with this disorder have a propensity to develop thrombosis, myelofibrosis, and leukemia …
with this disorder have a propensity to develop thrombosis, myelofibrosis, and leukemia …
相关搜索
- essential thrombocythemia prognostic factors
- essential thrombocythemia life expectancy
- essential thrombocythemia survival figures
- essential thrombocythaemia myeloid metaplasia
- essential thrombocythemia criteria for the diagnosis
- essential thrombocythemia complication rates
- essential thrombocythemia risk stratification
- evolution in a series myeloid metaplasia
- essential thrombocythemia consecutive patients
- actuarial probability myeloid metaplasia
- essential thrombocythemia idiopathic myelofibrosis
- essential thrombocythemia leukemic transformation
- essential thrombocythemia polycythemia vera
- essential thrombocythemia young patients
- essential thrombocythemia hemostatic complications